IDA
IDACORP INCPrice
Daily candles with volume. Pins mark insider trades, rating changes, 13F stakes, reports, catalysts and short-interest jumps.
- S Feb 23 2 insiders sell $328.2K at $142.71
- S Mar 3 1 insider sell $210.8K at $142.51
- R May 15 IDACORP filed a prospectus supplement for an at-the-market (ATM) equ…
- S May 29 1 insider sell $211.4K at $140.95
- S Jun 10 1 insider sell $213.0K at $142.03
- A Jul 22 Wells Fargo upgrades
Signal stack
Where each data set points today.
- InsidersBEARISH
5 insiders sold $963.5K.
- InstitutionsBULLISH
Q2 2026: 38 added (2 new), 14 trimmed or exited. Largest new: M&G $14.6M, Boston Partners $13.4M.
- AnalystsBULLISH
10 of 12 rate it Buy or better. Every target is above the price.
- Short sellersBUILDING
Short interest +20.2% to 6.33M shares. 9.3 days to cover, ≈10.9% of shares.
- TrendUPTREND
4% above its 50-day average.
Who's buying
13F· Q2 2026| Fund | Move | Value |
|---|---|---|
| FMR LLC | ADD | $334.0M |
| Capital World Investors | ADD | $297.0M |
| Pictet Asset Management Holding SA | DOUBLED | $259.1M |
| CITADEL ADVISORS LLC | DOUBLED | $136.2M |
| Neuberger Berman Group LLC | TRIM | $133.6M |
| GOLDMAN SACHS GROUP INC | ADD | $92.8M |
| AMERIPRISE FINANCIAL INC | ADD | $89.7M |
| UBS Group AG | ADD | $78.5M |
Quarterly 13F filings are due 45 days after each quarter ends.
The Street
12 analystsPrice is below the lowest target. Median implies +9%.Targets as of Oct 26, 2026.
| Date | Firm | Rating |
|---|---|---|
| Oct 21, 2026 | Morgan Stanley MAINTAIN | Overweight |
| Oct 9, 2026 | Barclays MAINTAIN | Overweight |
| Sep 18, 2026 | Morgan Stanley MAINTAIN | Overweight |
| Aug 21, 2026 | Morgan Stanley MAINTAIN | Overweight |
| Aug 3, 2026 | Barclays MAINTAIN | Overweight |
| Jul 31, 2026 | Wells Fargo MAINTAIN | Equal-Weight |
Insider ledger
Form 4| Date | Insider | Type | Value |
|---|---|---|---|
| Jun 10, 2026 | Richins Adam J EVP and COO (IPC) | SELL | $213.0K |
| Jun 1, 2026 | Miller Sharon L. Director | AWARD | 689 sh |
| May 29, 2026 | Hanchey James Bo D VP of Cust Op & CSO (IPC) | SELL | $211.4K |
| Mar 3, 2026 | Tatum Timothy E VP Regulatory Affairs (IPC) | SELL | $210.8K |
| Mar 1, 2026 | Jorgensen Nate Director | AWARD | 1,007 sh |
| Mar 1, 2026 | MORRIS SUSAN Director | AWARD | 1,007 sh |
| Mar 1, 2026 | Bolano Odette C Director | AWARD | 1,007 sh |
| Mar 1, 2026 | Kennedy Michael J. Director | AWARD | 1,007 sh |
Earnings setup
EstimatesRevision history: 🔒 Fresh data, subscribers only
| Period | EPS est. | Range | 30D rev. | Revenue |
|---|---|---|---|---|
| Current Q | 🔒 Fresh data, subscribers only | |||
| Next Q | 🔒 Fresh data, subscribers only | |||
| Current FY | 🔒 Fresh data, subscribers only | |||
| Next FY | 🔒 Fresh data, subscribers only | |||
| Date | Member | Type | Amount |
|---|---|---|---|
| Mar 3, 2026 | 🔒 Fresh data, subscribers only | BUY |
Short side
FINRA· Sep 30, 2026SecBot reports
4 filings · 0 bullish · 1 bearish · 1 mixed · 2 neutral- NEUTRAL 8-KJul 30, 2026
IDACORP reported Q2 2026 EPS of $1.79, slightly above consensus of $1.78, and raised the lower end…
The raised guidance lower end suggests management sees improving trends, but the modest EPS beat and ongoing dilution from equity issuance limit upside. Watch for regulatory decisions on rate cases…
- MIXED INST-CLUSTERJun 13, 2026
A mixed institutional cluster in IDACORP (IDA) for Q1 2026 shows 22 buyers accumulating $323.2M in…
The divergence between major active managers (Capital World buying $169.7M new vs. Capital International exiting $51.5M) suggests uncertainty around IDA's regulatory outlook or rate case outcomes…
- BEARISH 424B5May 15, 2026
IDACORP filed a prospectus supplement for an at-the-market (ATM) equity offering of up to $600…
Monitor IDACORP's quarterly disclosures for the number of shares sold under the ATM program. The forward sale structure delays dilution but creates overhang. Watch for any acceleration of sales or…
- NEUTRAL CLUSTERFeb 23, 2026
Two IDACORP insiders were granted shares in a non-cash transaction, totaling 2,014 shares with no…
No actionable trading signal; treat as routine corporate grant activity. Monitor for any open-market sales following vesting dates.
All IDA filing & press-release reports (4)
- 8-K reportJul 30, 2026
- INST-CLUSTER reportJun 13, 2026
- 424B5 reportMay 15, 2026
- CLUSTER reportFeb 23, 2026